Protocol summary

Study aim
This study purpose is to investigate the effectiveness of web-based training programs, self-hypnosis and bioenergy economy on awareness, quality of life, anxiety and depression and severity of symptoms in IBS patients
Design
The randomized clinical trial, with two factorial groups, blinded outcome assessment, phase 3 on 120 patients, that were randomized by the Random Allocation Software
Settings and conduct
In this trial, 120 eligible patients were selected among referring cases to the gastroenterology and psychiatry clinics of Isfahan Al-Zahra hospital and will be randomly divided into 3 groups. All patients are assessed before and after training by standard relative questionnaires. The researcher assessing the outcomes will not be aware of randomization.
Participants/Inclusion and exclusion criteria
Inclusion Criteria: Diagnosis of moderate to severe IBS based on ROME III criteria and exclusion of potential organic causes by gastroenterology specialists Basic literacy skills Ability to work with and access software applications. Exclusion Criteria: Depression disorders, bipolar disorders, or psychotic disorders based on DSM-V diagnostic criteria Suicidal ideation or plans Antidepressant or antianxiety medications Participation in psychotherapeutic programs Pregnancy or breastfeeding History of bowel surgery Substance abuse
Intervention groups
All participants undergo a 6-week training on various aspects of Irritable Bowel Syndrome (IBS). The first group, designated as the control group, receives only basic training. The second group, in addition to basic training, simultaneously undergoes Gut-Directed Hypnotherapy, through audio files and educational brochures. The third group, apart from basic training, also receives weekly training on bioenergy economics for IBS, using audio files and brochures.
Main outcome variables
Symptom severity, depression, anxiety, quality of life

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20190404043159N6
Registration date: 2024-01-08, 1402/10/18
Registration timing: prospective

Last update: 2024-01-08, 1402/10/18
Update count: 0
Registration date
2024-01-08, 1402/10/18
Registrant information
Name
Mohammad Reza Sharbafchi
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 31 3222 2475
Email address
sharbafchi@med.mui.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2024-01-21, 1402/11/01
Expected recruitment end date
2024-05-20, 1403/02/31
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparative study of the impact of educational programs, self-hypnosis, and web-based bioenergy economics on the severity of symptoms, awareness, quality of life anxiety and depression in patients with irritable bowel syndrome
Public title
Impact of educational programs, self-hypnosis, and web-based bioenergy economics on patients with irritable bowel syndrome
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Both male and female participants aged 18 to 65 years Diagnosis of moderate to severe IBS based on ROME III criteria and exclusion of potential organic causes by gastroenterology specialists Basic literacy skills (reading and writing) Ability to work with and access software applications Satisfaction to participate in the study
Exclusion criteria:
Diagnosis of any organic disease during the study period that renders continued participation impossible Diagnosis of depression disorders, bipolar disorders, or psychotic disorders based on DSM-V diagnostic criterias assessed by a psychiatrist and psychiatric assistant Serious suicidal thoughts or plans at the time of study entry Use of antidepressant or antianxiety medications within 2 weeks prior to study entry Participation in psychotherapeutic programs within 2 months prior to study entry Pregnant or breastfeeding History of bowel surgery Substance abuse since the onset of symptoms
Age
From 18 years old to 65 years old
Gender
Both
Phase
3
Groups that have been masked
  • Investigator
  • Outcome assessor
Sample size
Target sample size: 120
Randomization (investigator's opinion)
Randomized
Randomization description
In this study randomization performs based on the blocked randomization method. Information such as the number of study groups (3 main groups: 2 intervention groups (for example A,B) and a control group (for example (C), block size (a multiple of the number of groups that will be chosen in this study to reduce the complexity of the work, size 4) and the total number of patients (sample size 120 people), were enter into the online software machines specific for this calculation (for example available at https://www.sealedenvelope.com/simple-randomiser/v1/lists) and according to the codes that it is obtained by the final analysis (for example (group B 1, 4, 1), each of the patients being studied is given a specific code respectively. Blocking is usually used in order to create a balance in the number of samples assigned to each of the studied groups. In this method, equal blocking will be used. In this way, the samples are randomized in two groups as much as possible.
Blinding (investigator's opinion)
Double blinded
Blinding description
One researcher performs randomization of individuals into three groups and then sets up the receipt of web-based programs. The second researcher, who is unaware of the group assignments, evaluates patients using the questionnaires.
Placebo
Not used
Assignment
Factorial
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Esfahan university of Medical sciences
Street address
No. 18, Hezar Jarib Ave., Daneshgah Blvd., Isfahan
City
Isfahan
Province
Isfehan
Postal code
۸۱۳۷۸۶۶۵۱۵
Approval date
2023-07-15, 1402/04/24
Ethics committee reference number
IR.MUI.MED.REC.1402.149

Health conditions studied

1

Description of health condition studied
Irritable bowel syndrome
ICD-10 code
K58
ICD-10 code description
Irritable bowel syndrome

Primary outcomes

1

Description
Severity of Irritable Bowel Syndrome symptoms
Timepoint
Before and after 6 weeks training
Method of measurement
The irritable bowel severity scoring system (IBSSS)

2

Description
Depression
Timepoint
Before and after 6 weeks training
Method of measurement
Hospital Anxiety and Depression Scale (HADS)

3

Description
Anxiety
Timepoint
Before and after 6 weeks training
Method of measurement
Hospital Anxiety and Depression Scale (HADS)

4

Description
Quality of life
Timepoint
Before and after 6 weeks training
Method of measurement
Irritable Bowel Syndrome Quality of Life (IBS-QOL-34)

5

Description
Awareness level
Timepoint
Before and after 6 weeks training
Method of measurement
Which number from 0 to 100 rates your awareness level of your disease?

Secondary outcomes

empty

Intervention groups

1

Description
First intervention group: in addition to basic training, simultaneously undergoes Gut-Directed Hypnotherapy training, through audio files. These audio files include self-hypnosis training, which are recorded by the hypnotherapist and patients practice them at home between weekly sessions. According to the standard, the hypnotherapy process includes the following stages: induction, relaxation, deepening, therapeutic suggestions focused on the GI system, ego strengthening and emergence.
Category
Treatment - Other

2

Description
Second intervention group: apart from basic training, also receives weekly training on bio-energy economics for IBS, using audio files and brochures.These part include mental and behavioral, and motor techniques that reduce psychosomatic symptoms by regulating body movements and ergonomics and proportional distribution of biological energy. The 6-week IBS program is the abbreviated form of this program, which includes four sections relating to the body, thoughts, others, and existence.
Category
Treatment - Other

3

Description
Control group: undergo a 6-weeks basic training on various aspects of Irritable Bowel Syndrome (IBS) such as disease definition, signs and symptoms, diagnosis, lab tests, medical and non medical treatments, and prognosis.
Category
Treatment - Other

Recruitment centers

1

Recruitment center
Name of recruitment center
Al-Zahra Hospial
Full name of responsible person
Mohammad Reza Sharbafchi
Street address
Department of Psychiatry, Al-Zahra Hospital, Hezar Jarib Street
City
Isfahan
Province
Isfehan
Postal code
8174675731
Phone
+98 31 3620 2020
Email
sharbafchi@med.mui.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Shaghayegh Haghjoo
Street address
No. 18, Hezar Jarib Ave., Daneshgah Blvd., Isfahan
City
Isfahan
Province
Isfehan
Postal code
8174673461
Phone
+98 31 3668 0042
Email
haghjoo.sh@med.mui.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Esfahan University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Mohammad Reza Sharbafchi
Position
Assistant professor
Latest degree
Specialist
Other areas of specialty/work
Psychiatrics
Street address
No. 22, Roshd Ave., Daneshgah Blvd., Isfahan
City
Isfahan
Province
Isfehan
Postal code
8174673461
Phone
+98 31 3668 0042
Email
sharbafchi@med.mui.ac.ir

Person responsible for scientific inquiries

Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Mohammad Reza Sharbafchi
Position
Associate professor
Latest degree
Specialist
Other areas of specialty/work
Psychiatrics
Street address
No. 22, Roshd Ave., Daneshgah Blvd., Isfahan
City
Isfahan
Province
Isfehan
Postal code
8174673461
Phone
+98 31 3668 0042
Email
sharbafchi@med.mui.ac.ir

Person responsible for updating data

Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Mohammad Reza Sharbafchi
Position
Associate professor
Latest degree
Specialist
Other areas of specialty/work
Psychiatrics
Street address
No. 22, Roshd Ave., Daneshgah Blvd., Isfahan
City
Isfahan
Province
Isfehan
Postal code
8174673461
Phone
+98 31 3668 0042
Email
sharbafchi@med.mui.ac.ir

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
No - There is not a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
No - There is not a plan to make this available
Data Dictionary
No - There is not a plan to make this available
Title and more details about the data/document
All data can be shared after people have requested.
When the data will become available and for how long
Six months after publishing the results
To whom data/document is available
Academic researchers
Under which criteria data/document could be used
Scientific uses
From where data/document is obtainable
Isfahan University of Medical Sciences website
What processes are involved for a request to access data/document
Clear request on the site to access the data by the individual and then review the request by the research assistant within 2 weeks and then allow access to the data
Comments
Loading...